Bond van Cannabis Detaillisten
Back to news
12 June 2025

European Drug Report 2025 (EUDA)

On 5 June 2025, the EU Drugs Agency (EUDA) published the annual European Drug Report.

This is an English translation. The original Dutch article is authoritative.

On 5 June, the annual European Drug Report 2025 was published by the EU Drugs Agency (EUDA). The report contains data up to the end of 2024. Below are the most important findings regarding cannabis and broader developments in the drug market.

1. Cannabis remains the most widely used illegal drug in Europe

  • Approximately 8% of the adult EU population (18–64 years) used cannabis in the past year.
  • THC levels continue to rise:

    • - Average THC value in hash (cannabis resin): 23% - Average THC value in weed (herbal cannabis): 11%

  • There is increased diversity in cannabis products, including oils, edibles, and vape products.

2. Production of cannabis within the EU

  • Cannabis is produced illegally in several EU member states.
  • Integrated production facilities have been found, especially in the Netherlands and Spain.
  • There is increasing attention to the environmental damage caused by illegal cannabis cultivation.

3. Unregulated markets: cocaine and synthetic drugs increasing

  • In 2023, a record amount of 419 tonnes of cocaine was seized within the EU.
  • Large quantities of synthetic drugs, including amphetamine, MDMA, and methamphetamine, are produced in the EU.
  • 37 tonnes of synthetic cathinones (often referred to as 'designer drugs') were reported in 2023.

4. New opioids on the rise

  • Nitazenes, highly potent synthetic opioids, have been detected in multiple locations in Europe.
  • These substances are linked to an increased risk of overdoses.
  • In 2023, 26 new psychoactive substances were reported, several of which are opioid-like.

5. Drug-related violence and subversion

  • In several member states, there is an increase in violence related to the illegal drug trade.
  • The report explicitly mentions violent incidents in urban areas, including in the vicinity of the European Parliament in Brussels.
  • Large seaports remain important entry points for drugs into the EU.

6. Public health and treatment

  • Cannabis is the most reported drug in first-time treatments for drug-related issues.
  • In total, more than 97,000 first-time treatments for cannabis use took place in 2022.
  • Cannabis is often used in combination with other substances.

---

The full report can be found via the website of the EU Drugs Agency:

All news articles